Carbohydrate antigens have been identified as significant antigens in
many human tumors either by analyzing antibodies in patients' sera or
by using monoclonal antibodies of either mouse or human origin, Three
carbohydrate epitopes present on cancer-associated mucins [sialyl-Lewi
s A (SLA), sialyl-Lewis X (SLX), and siayl-Tn (STn)] may have function
al significance in metastasis, Subsequently, these antigens are consid
ered as targets for active specific immunotherapy. Carbohydrates, as T
-cell-independent antigens, often elicit diminished immune responses,
To overcome this drawback, carbohydrates are typically coupled to prot
ein carriers to elicit immunoglobulin G (IgG) responses as opposed to
low-affinity IgM responses, which oftentimes accompanies carbohydrate-
based immunizations, In addition, some complex carbohydrates are diffi
cult to synthesize, This latter aspect is further magnified if one con
siders that clustering of epitopes on neoglycoproteins must be emulate
d in the synthesis process, leading to multiple presentation or tandem
repeats of the synthetic carbohydrate immunogen, Here, we examine the
hypothesis that peptides that mimic carbohydrates might be developed
to induce immune responses that target and mediate the killing of tumo
r cells, particularly breast cancer cells in an adjuvant-type setting,
We have found that carbohydrate-mimicking peptides retain carbohydrat
e-like conformations, inducing anti-carbobydrate immune responses agai
nst breast tumor cells and mediating their killing by a complement-dep
endent mechanism.